Rebalix
Invesco · sheet of 5 September 2026
Invesco · sheet of 5 September 2026ETF sheet · official issuer and register data
Invesco MSCI USA UCITS ETF Dist
MXUD · IE00BK5LYT47 · class Dist · USD · domicile Ireland
Equity · United StatesSFDR art. 6
Index tracked: MSCI USA Total Return (Net) Index
- TER
- 0.05%+ trans. 0.07%
- Fund size
- 9.7 bn EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Synthetic (swap)
- Income
- Distributingquarterly
Launch 11 Nov 2019 · costs from the KID as of 14 Aug 2026 · 194 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Investment objective: The investment objective of the Fund is to achieve the net total return performance of the MSCI USA Index (the "Index"), less fees, expenses and transaction costs.
Intended Retail Investor
The Fund is intended for investors aiming for income and long term capital growth, who may not have specific financial expertise but are able to make an informed investment decision based on this document, the supplement, and the prospectus, have a risk appetite consistent with the risk indicator displayed below and understand that there is no…
Performance since series start (in euro) — base 100
11 Nov 2019 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +20.5% |
| 3 years | +65.9% |
| 5 years | +80.6% |
| 10 years | series too young |
| Since series start | +160.8% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.98% | 15.19% | 17.39% |
| Max drawdown | −9.33% | −19.41% | −26.33% |
| Sharpe | 1.29 | 1.07 | 0.54 |
| Sortino | 1.86 | 1.56 | 0.76 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · MXUD · IE00BK5LYT471
RebalixMXUD · IE00BK5LYT47 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: under review: anomalies in the fund or index series
Distributions · per share, in USD
Frequency: quarterly · last 12 months: 1.0867 USD (1.05% of NAV) · last ex-date 11 Jun 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.545 | — |
| 2025 | 4 | 1.0498 | +1.33% |
| 2024 | 4 | 1.0329 | +1.61% |
| 2023 | 4 | 0.9489 | +1.85% |
| 2022 | 4 | 0.8525 | +1.31% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 194 securities · top-10 weight = 40.8%
| Top holdings | Weight |
|---|---|
| 5.8% | |
| 5.0% | |
| 4.7% | |
| 4.4% | |
| 3.9% | |
| 3.9% | |
| 3.5% | |
| 3.4% | |
| 3.4% | |
| 3.0% |
Listing venues
ESMA register (FIRDS) and official exchange lists
MXUD · Borsa Italiana (ETFplus)
6PSE · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 14 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BK5LYT47
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BK5LYT47
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · MXUD · IE00BK5LYT472